On January 7, 2020 Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, reported that it will present at Biotech Showcase 2020, to be held January 13–15, 2020 at the Hilton San Francisco Union Square (Press release, Paragon Genomics, JAN 7, 2020, View Source [SID1234552823]). Paragon Genomics CEO Tao Chen will give a corporate presentation and meet with investors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Date: Tuesday, January 14, 2020
Presentation Time: 1:45 pm PST
Room: Yosemite C (Ballroom Level)
Tao Chen commented, "During the past year Paragon Genomics launched important new products for our growing customer base and recorded substantial growth in product sales in both the U.S. and China. Our CleanPlex technology has the potential to make NGS-based genomic analyses across a wide variety of applications faster, easier, more accurate, more economical and more feasible. Our clients have successfully applied our technologies to applications such as tumor profiling, inherited disease testing, reproductive health, drug discovery, single cell analysis and agrigenomics. We anticipate robust expansion in 2020 and look forward to sharing our exciting story with early stage life science investors in San Francisco next week."
Paragon Genomics’ CleanPlex is a proprietary, ultra-high multiplexed NGS target enrichment technology featuring an innovative PCR background cleaning chemistry that allows tens of thousands of amplicons to be multiplexed in a single reaction pool, allowing a large number of targets to be interrogated in a single assay. The CleanPlex technology is available as ready-to-use panels or as customized assays designed and optimized using the company’s advanced panel design algorithm.
Investors interested in scheduling a meeting with Paragon Genomics leadership in San Francisco should contact [email protected]. Investors interested in attending Biotech Showcase can visit informaconnect.com/biotech-showcase/ for more information.